- Home
- RNXT vs GRF Comparison
RNXT vs GRF Comparison
Compare RNXT & GRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- GRF
- Stock Information
- Founded
- RNXT 2012
- GRF 1989
- Country
- RNXT United States
- GRF United States
- Employees
- RNXT N/A
- GRF N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- GRF Finance/Investors Services
- Sector
- RNXT Health Care
- GRF Finance
- Exchange
- RNXT Nasdaq
- GRF Nasdaq
- Market Cap
- RNXT 44.6M
- GRF 42.6M
- IPO Year
- RNXT 2021
- GRF N/A
- Fundamental
- Price
- RNXT $1.26
- GRF $10.52
- Analyst Decision
- RNXT Strong Buy
- GRF
- Analyst Count
- RNXT 2
- GRF 0
- Target Price
- RNXT $7.50
- GRF N/A
- AVG Volume (30 Days)
- RNXT 648.4K
- GRF 3.0K
- Earning Date
- RNXT 11-12-2025
- GRF 01-01-0001
- Dividend Yield
- RNXT N/A
- GRF 3.70%
- EPS Growth
- RNXT N/A
- GRF N/A
- EPS
- RNXT N/A
- GRF 1.16
- Revenue
- RNXT $662,000.00
- GRF N/A
- Revenue This Year
- RNXT $2,895.35
- GRF N/A
- Revenue Next Year
- RNXT $313.04
- GRF N/A
- P/E Ratio
- RNXT N/A
- GRF $8.15
- Revenue Growth
- RNXT N/A
- GRF N/A
- 52 Week Low
- RNXT $0.75
- GRF $7.93
- 52 Week High
- RNXT $1.69
- GRF $10.19
- Technical
- Relative Strength Index (RSI)
- RNXT 58.65
- GRF 52.48
- Support Level
- RNXT $1.19
- GRF $10.50
- Resistance Level
- RNXT $1.45
- GRF $10.69
- Average True Range (ATR)
- RNXT 0.12
- GRF 0.11
- MACD
- RNXT 0.02
- GRF -0.03
- Stochastic Oscillator
- RNXT 62.75
- GRF 3.85
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About GRF Eagle Capital Growth Fund Inc.
Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock by giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.